YAP1 and cancer: Of the 218 FDA-approved drugs, chemotherapeutic agents that inhibit DNA synthesis (teniposide, dacarbazine, doxorubicin, triethylenemelamine, nitrogen mustard, etoposide, and thiotepa) topped the list, which might be effective in treating cancer patients with high YAP1 expression.